Symbol
MAZE on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock, par value $0.001 per share
Latest Disclosed Ownership
2.46M shares
Security Ownership
5.6%

James Tananbaum ownership in Maze Therapeutics, Inc. Common Stock, par value $0.001 per share (MAZE)

2025-02-07 - James Tananbaum has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.46M shares of Maze Therapeutics, Inc. Common Stock, par value $0.001 per share (MAZE). This represents 5.6% percent ownership of the company.